Giant Papillary ConjunctivitisSymptoms, Doctors, Treatments, Advances & More
Learn About Giant Papillary Conjunctivitis
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Baylor College Of Medicine - Ophthalmology
Stephen Pflugfelder, MD, is dedicated to delivering high-quality, compassionate care to Houston and nearby communities. Stephen Pflugfelder specializes in Ophthalmology (Eye) and works at BCM Ophthalmology. To make an appointment, please call (713) 798-6100. To review all accepted insurance carriers, please visit: https://www.stlukeshealth.org/patients-visitors/patients/billing-insurance/insurances-accepted. Dr. Pflugfelder is rated as an Elite provider by MediFind in the treatment of Giant Papillary Conjunctivitis. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Interstitial Keratitis, Dry Eye Syndrome, Conjunctivitis (Pink Eye), Dacryoadenitis, and Corneal Transplant. Dr. Pflugfelder is currently accepting new patients.
Andrea Leonardi practices practicing medicine in Padova, Italy. Ms. Leonardi is rated as an Elite expert by MediFind in the treatment of Giant Papillary Conjunctivitis. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Giant Papillary Conjunctivitis, Allergic Conjunctivitis, Vernal Keratoconjunctivitis, and Conjunctivitis (Pink Eye).
Nobuyuki Ebihara practices practicing medicine in Urayasu, Japan. Mr. Ebihara is rated as an Elite expert by MediFind in the treatment of Giant Papillary Conjunctivitis. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Giant Papillary Conjunctivitis, Vernal Keratoconjunctivitis, Allergic Conjunctivitis, Vitrectomy, and Trabeculectomy.
Summary: The aim of the study is to investigate whether patients with moderate-to-severe VKC and keratitis will benefit from the addition of Diquafosol ophthalmic solution in terms of symptoms and signs of VKC, tear film metrics, ocular surface inflammation and quality of life. Potential beneficial effect of Diquafosol treatment on top of current standard use of topical immunosuppressant therapy in VKC wou...
Summary: This study aims to obtain the lacrimal fingerprint for frequent pathologies of the ocular surface and establish a normative base for each of them.